Skew Flap vs Long Posterior Flap for Below Knee Amputation Early and Short- Term Outcomes
NCT ID: NCT06499506
Last Updated: 2025-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-07-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is two main methods for constructing the myocutaneous flaps in below knee amputation; the long posterior flap (LPF) and skew flap (SF).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Radial Forearm Flap In Reconstruction Of Upper Limb Injuries
NCT06319586
Comparison Between Functional Outcomes of Flexor Tendon Repair Under WALANT and Brachial Plexus Block
NCT06149962
Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
NCT02289976
Correlation Between the Volume Flow of the CFA After Angioplasty of Critical Ischemic Limb and Wound Healing
NCT04672668
Anterolateral Tigh (ALT) Flaps Oxygenation Monitoring by NIRS
NCT06744387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient position The patient lies in the supine position. Technique The limb is prepared by an application of povidone iodine solution in the ward 2 h before surgery. The foot and any septic lesion is isolated. The whole limb is wrapped in a dry sterile sheet. Penicillin and metronidazole prophylaxis is used routinely.
The operation is performed under general anesthesia with a regional anesthetic technique.
The skin flaps are marked on the skin before any incision. And the skin flaps are semicircular. based on a line around the limb at right angles to its long axis, drawn at the plane of bone section 10-12cm from the joint line at the tibial plateau.
The skin flaps are cut which includes the fat and deep fascia. but these are not stripped from the underlying muscle more than is required to gain access to the anterior tibial compartment. The saphenous veins are ligated. The periosteum over the tibia is incised where it is exposed and elevated with the skin flap to 2 cm above the line of bone section.
The anterior tibial nerve and the peroneal nerve are divided and allowed to retract while the vessels are ligated. The fibula is divided 2cm above the line of tibial bone section.
The tibia is divided with a GIGLI saw. Traction on the bone hook exposes the tibialis posterior muscle and this is divided at the line of distal bone section which exposes the posterior tibial artery and its venae comitantes. the posterior tibial nerve and the peroneal artery and its venae comitantes. ligatures applied to each of the vascular bundles. The gastrocnemius and soleus muscle mass can then be separated from the tibia and fibula of the specimen while hemostasis is maintained. The muscle mass is cut transversely, thus freeing the specimen; this must allow a length of muscle below the bone end at least equal to the diameter of the leg.
The protruding muscle mass is then thinned from the line of bone section to its extremity .
Careful homeostasis is essential and the muscle must not be compressed due to too much bulk or tight constricting sutures.
A suction tube drain is drawn through the lateral aspect of the stump above the suture line and placed to collect any fluid in the vicinity of the bone ends.
The drain can be removed in 48-72 h; the sutures are removed at 15- 21 days. Follow up Patients will be followed up prospectively intraoperative, during postoperative hospital admission and late in outpatient clinic.
Major adverse clinical events (MACE) are carefully monitored. Follow up include immediate postoperative complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Skew Flap
skew Flap technique for below knee amputation
Below knee amputation
trans tibial amputation one hand breadth below tibial tuberosity
Long Posterior Flap
Long Posterior Flap for Below knee amputation
Below knee amputation
trans tibial amputation one hand breadth below tibial tuberosity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Below knee amputation
trans tibial amputation one hand breadth below tibial tuberosity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with aggressive diabetic foot infections or gangrene, or both.
* Patients with extensive venous ulceration.
* Patients following major trauma with unsalvageable limb.
* Patients with nonfunctioning damaged limb as in Charcot joint disease.
* Patients with extensive limb sepsis.
Exclusion Criteria
* Patients with bad general condition.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Ibrahim Abdelmageed
Ibrahim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag University Hospital
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-24-06-15MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.